Nuclear receptor assays
The assays include human and rat PXR (SXR) and AhR and are described as important in drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
Puracyp is a biotechnology company developing methods to assess the safety of new drugs before clinical use.
The company offers cell-based systems for examining nuclear receptor activation, the first step in drug-metabolizing enzyme induction.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The assays include human and rat PXR (SXR) and AhR and are described as important in drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
Studies assess metabolic stability, metabolism kinetics, P450 reaction phenotyping, and inhibition of P450 oxidation by new chemical entities.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.